Transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiation

Abstract Background Development of primary open-angle glaucoma (POAG) is associated with the malfunctioning trabecular meshwork (TM). Cell therapy offers great potential for the treatment of POAG, but requires the generation of functional TM cells in vitro to replace the lost/dysfunctional cells. TM...

Full description

Bibliographic Details
Main Authors: Padmapriya Sathiyanathan, Cheryl Y. Tay, Lawrence W. Stanton
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Genomics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12864-017-3758-7
id doaj-aac059d43a9c40279c60d7139278c130
record_format Article
spelling doaj-aac059d43a9c40279c60d7139278c1302020-11-24T22:25:27ZengBMCBMC Genomics1471-21642017-05-0118111310.1186/s12864-017-3758-7Transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiationPadmapriya Sathiyanathan0Cheryl Y. Tay1Lawrence W. Stanton2Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR)Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR)Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR)Abstract Background Development of primary open-angle glaucoma (POAG) is associated with the malfunctioning trabecular meshwork (TM). Cell therapy offers great potential for the treatment of POAG, but requires the generation of functional TM cells in vitro to replace the lost/dysfunctional cells. TM differentiation in vitro from various stem cell types must be monitored by the expression of specific markers. However, no single definitive marker of the TM has been identified. Results To identify robust markers of TM differentiation, we performed global transcriptome profiling using high-density oligonucleotide microarray on ex vivo TM tissue and cultured TM progenitors. Corneal and scleral tissues were also used in the analysis. After removal of genes expressed in the cornea and sclera, 18 genes were identified that were differentially expressed in the TM relative to the other samples. CDH23, F5, KCNAB1, FGF9, SPP1, and HEY1 were selected among the genes highly expressed in the TM, together with BDNF which was repressed, compared to progenitors for further investigation. Expression analysis by qPCR verified the differential expression and immunofluorescence of the anterior segment confirmed strong expression in the TM. Conclusions Three independent cohort of expression studies have identified novel markers, fitting in identifying TM cells and in evaluating directed TM differentiation in vitro.http://link.springer.com/article/10.1186/s12864-017-3758-7Human trabecular meshworkMarkersDifferentiationGlaucoma
collection DOAJ
language English
format Article
sources DOAJ
author Padmapriya Sathiyanathan
Cheryl Y. Tay
Lawrence W. Stanton
spellingShingle Padmapriya Sathiyanathan
Cheryl Y. Tay
Lawrence W. Stanton
Transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiation
BMC Genomics
Human trabecular meshwork
Markers
Differentiation
Glaucoma
author_facet Padmapriya Sathiyanathan
Cheryl Y. Tay
Lawrence W. Stanton
author_sort Padmapriya Sathiyanathan
title Transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiation
title_short Transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiation
title_full Transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiation
title_fullStr Transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiation
title_full_unstemmed Transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiation
title_sort transcriptome analysis for the identification of cellular markers related to trabecular meshwork differentiation
publisher BMC
series BMC Genomics
issn 1471-2164
publishDate 2017-05-01
description Abstract Background Development of primary open-angle glaucoma (POAG) is associated with the malfunctioning trabecular meshwork (TM). Cell therapy offers great potential for the treatment of POAG, but requires the generation of functional TM cells in vitro to replace the lost/dysfunctional cells. TM differentiation in vitro from various stem cell types must be monitored by the expression of specific markers. However, no single definitive marker of the TM has been identified. Results To identify robust markers of TM differentiation, we performed global transcriptome profiling using high-density oligonucleotide microarray on ex vivo TM tissue and cultured TM progenitors. Corneal and scleral tissues were also used in the analysis. After removal of genes expressed in the cornea and sclera, 18 genes were identified that were differentially expressed in the TM relative to the other samples. CDH23, F5, KCNAB1, FGF9, SPP1, and HEY1 were selected among the genes highly expressed in the TM, together with BDNF which was repressed, compared to progenitors for further investigation. Expression analysis by qPCR verified the differential expression and immunofluorescence of the anterior segment confirmed strong expression in the TM. Conclusions Three independent cohort of expression studies have identified novel markers, fitting in identifying TM cells and in evaluating directed TM differentiation in vitro.
topic Human trabecular meshwork
Markers
Differentiation
Glaucoma
url http://link.springer.com/article/10.1186/s12864-017-3758-7
work_keys_str_mv AT padmapriyasathiyanathan transcriptomeanalysisfortheidentificationofcellularmarkersrelatedtotrabecularmeshworkdifferentiation
AT cherylytay transcriptomeanalysisfortheidentificationofcellularmarkersrelatedtotrabecularmeshworkdifferentiation
AT lawrencewstanton transcriptomeanalysisfortheidentificationofcellularmarkersrelatedtotrabecularmeshworkdifferentiation
_version_ 1725757539015983104